Advertisement

Pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in miniature donkeys

View More View Less
  • 1 Texas Veterinary Medical Center, Texas A & M University, College Station, TX 77843.
  • | 2 Texas Veterinary Medical Center, Texas A & M University, College Station, TX 77843.
  • | 3 Texas Veterinary Medical Center, Texas A & M University, College Station, TX 77843.
  • | 4 Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA 99163.

Abstract

Objective—To describe the pharmacokinetics of phenylbutazone and oxyphenbutazone after IV administration in miniature donkeys.

Animals—6 clinically normal miniature donkeys.

Procedure—Blood samples were collected before and 5, 10, 20, 30, 45, 60, 90, 120, 180, 240, 300, 360, and 480 minutes after IV administration of phenylbutazone (4.4 mg/kg of body weight). Serum was analyzed in triplicate by use of high-performance liquid chromatography for determination of phenylbutazone and oxyphenbutazone concentrations. The serum concentration-time curve for each donkey was analyzed separately to estimate model-independent pharmacokinetic variables.

Results—Serum concentrations decreased rapidly after IV administration of phenylbutazone, and they reached undetectable concentrations within 4 hours. Values for mean residence time ranged from 0.5 to 3.0 hours (median, 1.1 hour), whereas total body clearance ranged from 4.2 to 7.5 ml/kg/ min (mean, 5.8 ml/kg/ min). Oxyphenbutazone appeared rapidly in the serum; time to peak concentration ranged from 13 to 41 minutes (mean, 26.4 minutes), and peak concentration in serum ranged from 2.8 to 4.0 mg/ml (mean, 3.5 μg/ml).

Conclusion and Clinical Relevance—Clearance of phenylbutazone in miniature donkeys after injection of a single dose (4.4 mg/kg, IV) is rapid. Compared with horses, miniature donkeys may require more frequent administration of phenylbutazone to achieve therapeutic efficacy. (Am J Vet Res 2001;62:673–675)